MedicGo
e-Cigarette or Vaping Product Use-Associated Lung Injury: Clinical, Radiologic, and Pathologic Findings of 15 Cases.
Metadata
Journalchest8.308Date
2020-Jun
Type
Case Report
Volume
2020-Jun / 157 : e181-e187
Author
MacMurdo M 1, Lin C 2, Saeedan MB 3, Doxtader EE 4, Mukhopadhyay S 4, Arrossi V 4, Reynolds J 4, Ghosh S 3, Choi H 5
Affiliation
  • 2. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
  • 3. Section of Thoracic Radiology, Imaging Institute, Cleveland Clinic, Cleveland, OH.
  • 4. Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
  • 5. Respiratory Institute, Cleveland Clinic, Cleveland, OH. Electronic address: [email protected]
Doi
PMIDMESH
Abstract
Since mid-2019, > 2,000 cases of e-cigarette or vaping product use-associated lung injury (EVALI) have been reported. Although initial reports suggested that this entity may be a form of inhalation-related lipoid pneumonia, subsequent studies indicate that EVALI represents various patterns of acute lung injury. Cases of EVALI continue to be reported, and public awareness of the epidemic is increasingly high. However, evidence surrounding optimal management of EVALI remains limited. In this case series, we report 15 cases of EVALI across a spectrum of severity, highlighting key radiologic, pathologic, and cytologic findings, and discuss management implications. In line with national findings, most patients with EVALI in the series vaped liquids containing tetrahydrocannabinol. Our imaging and pathologic findings support the notion that EVALI is a form of acute lung injury.
Keywords: acute lung injury e-cigarettes tetrahydrocannabinol vaping
Fav
Like
Download
Share
Export
Cite
8.3
Chestchest
Metadata
LocationUnited States
FromELSEVIER

No Data

© 2017 - 2020 Medicgo
Powered by some medical students